Medi-Tech Insights Research Reports

While AR and VR technologies were initially exclusively adopted by the gaming industry, various sectors including healthcare is increasingly recognizing its benefits and exploring the prospects of AR/VR for medical applications. Significant Potential for AR and VR in Healthcare market AR and VR in healthcare is currently a niche market but offers huge growth potential. Some of the applications include medical training, surgical planning, pain management, patient care management, and mental health treatment. The scope of application of AR and VR is rapidly growing with increasing number of startups entering into this space to offer variety of hardware and software targeting different areas of healthcare. Surging VC/PE Investments and Regulatory Approvals Accelerating Growth & Innovation The Covid-19 pandemic induced the world to go virtual. Last couple of years have marked a turning point with several hyped technologies like AR/VR finally becoming a reality in healthcare, ba...

Drug screening is majorly used at workplaces for testing employees, in the criminal justice system, pain management clinics, Federal drug testing programs and in hospitals. COVID-19 pandemic led to increase in drug abuse The COVID-19 crisis pushed more than 100 million people into unemployment. Mental health issues are also on the rise worldwide. This has led to potential increase in drug abuse. In parallel, drug traffickers have quickly recovered from initial setbacks caused by lockdown restrictions, driven in part by a rise in the use of technology (drug traffickers using online platforms etc.) and cryptocurrency payments that are operating outside the regular financial system. These factors are likely to increase demand for drug screening products/services. “The pandemic fueled  discussions about substance use disorders (SUDs), as drug and alcohol use along with the associated deaths from their overdoses increased. Confusion, loneliness, and unemployment caused more people...

  The life sciences software market (such as eTMF, LIMS, computer-aided drug discovery, RWE, ERP, CRM, QMS, virtual trials, patient recruitment software, patient & outcomes data management, etc.) is driven by the increasing R&D spend and pipeline, growing number and size of biotechs, Covid-accelerated decentralized trials, increasing cost efficiencies and shorter time to market. Rising Interest in Novel Software Solutions Specifically Designed for Biologics With rapidly expanding research on advanced therapies such as cell and gene therapies and personalized vaccines, there is robust demand for software solutions to maximize process and workflow efficiencies across services. The FDA predicts that by 2025, 10 to 20 cell and gene therapy products will be approved a year. To leverage growth opportunities, companies are entering/expanding into Biologics software space. Some of the key technology providers for CGT include Vineti, TrakCel, Be The Match, SAP, WellSky, Synthace...

A LIMS is a data management software that helps labs in automating their workflows, keeping track of data (associated with samples, instruments and QA/QC results, etc.), and data storage, processing and reporting. All of these features are crucial to sustain and improve productivity and efficiency of any biological lab, from pharma, biotech, environmental facilities, F&B to biobanking. Shift towards Cloud-based LIMS With the growing need for data sharing across and between organizations, traditional on-premise LIMS face challenge to survive in a data-driven world. On-premise systems lack scalability and easy integration, are often time-consuming and costly to implement and manage. The LIMS industry is witnessing rise in the adoption of cloud-based model as it can address most of these issues with quick deployment, minimum upfront costs, high flexibility and scalability making it affordable for even small to medium-size laboratories. Trending Subscription-based Pricing Model...

  RWE is the clinical evidence regarding usage and potential benefits/risks of a medical product based on analysis of the real-world data. RWE to play vital role in helping regulators formulating decisions RWE could potentially help FDA while making regulatory decisions about the safety and effectiveness of medical products such as identifying new safety issues post-approval or determine the effectiveness of a drug for a new indication or patient population. Citing the potential, the 21st Century Cures Act  (Cures Act, signed in 2016) required FDA to publish a framework for a program to evaluate the use of RWE in regulatory decision-making; FDA published the framework for this program in December 2018. As part of its RWE Program, FDA committed to understanding the full potential of RWD and RWE in regulatory decision-making. The agency has been holding workshops, funding demonstration projects, creating mobile and web applications that can collect RWD, and engaging with spo...

  Sepsis is a life-threatening medical emergency. It is body's reaction to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure. As per WHO, globally, sepsis affects around 49 million people each year. Early diagnosis of sepsis is critical for patient outcomes. However, diagnosing sepsis is not an easy task as there is no particular symptom or sign that are directly related to the disease.  Development of Rapid Diagnostic Tests/Point-of-Care Techniques Set to Drive the Sepsis Diagnostics Market Currently, clinicians possess limited technology needed to conduct multiplexed and fully quantitative diagnostic tests at the point of care with high sensitivity. Citing the need for rapid diagnostic tests, several research universities and product manufacturers are developing innovative rapid diagnostic tests/point-of-care techniques. For instance, Researchers at the University of Strathclyde have developed ...

The MedTech Contract Manufacturing Organizations  (CMO) market is growing slightly ahead of the underlying growth in MedTech market as a result of increased outsourcing by OEMs and higher growth rates in segments like Drug delivery and MIS (Minimally Invasive Surgery). Medi-Tech Insights’ latest research report on MedTech CMO market analyses the global market with respect to end-market segments, geography, technologies and materials. Based on our research, the global MedTech CMO market can be split into various end-market related segments like Orthopaedics, MIS, Cardiovascular, Surgical instruments, IVD and other end-market segments. While segments such as Orthopaedics are mature in terms of level of outsourcing, increasing use of robotics, single-use devices are causing higher growth. In terms of geography, United States followed by Germany, UK, Ireland, China, Malaysia and Singapore are some key countries with large presence of MedTech CMO sites. Metals and Polymers contribut...

Aging population, rising number of GI procedures, growing cases of colorectal cancer and screening mandates in many healthcare systems is driving the Gastrointestinal Devices MedTech market growth. Rising usage of robotics and focus on AI are offering further impetus for the market growth. Medi-Tech Insights’ latest research report on Gastrointestinal Devices MedTech market analyses the worldwide market with respect to product and geography. Based on product, the Gastrointestinal Devices MedTech market comprises of 4 segments, viz., GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic devices. Based on our research & interviews with industry experts, it is evident that GI endoscopes is the largest product segment. Within endoscope market, reusable endoscopes form major chunk of the market, owing to the fact that they are high-cost capital equipment with relatively greater adoption. However, single-use endoscope market is slated to grow faster. Shift driven by re...

The prevalence of allergic diseases globally has continued to grow in the industrialized world for more than 50 years. Allergies are the 6th leading cause of chronic illness in the U.S. and each year more than 50 million Americans experience various types of allergies. Continuously rising cases of allergic diseases and other related medical conditions has fueled the global allergy diagnostics market. Growing Prominence of mHealth in Allergy Diagnosis & Allergy Care The widespread availability of technology-based interventions such as mobile health in the clinical setting has enabled patients to play an active role in their medical care. Mobile health (mHealth) utilizes mobile communication devices such as computers, tablets and smartphones to improve patient education & self-management of diseases, help in remote surveillance of patient’s health, flow of data and information and disease management from first diagnosis to an optimized treatment. Advent of patient-facing mHealth ...

Healthcare data analytics combines real-time and historical data to predict trends, reveal actionable insights, and improve clinical, financial, and operational performance. Shift towards Evidence-based Care Model Data and analytics have been central to healthcare for decades. However, a major shift in how data is generated, aggregated and utilized is being witnessed as the healthcare industry moves from a fee-for-service to value-based care model. Key Growth Drivers: Healthcare Analytics Market The adoption of healthcare analytics is anticipated to grow rapidly worldwide as it can potentially reduce the cost of treatment, predict disease outbreaks, avoid preventable illnesses and improve the overall quality of care and life of patients. Key Challenges: Healthcare Analytics Market Healthcare data security and patient privacy issues, unstructured/fragmented data, ever-changing data, interoperability and data science skills gap are some of the key challenges to be addressed t...